Lupus Foundation of America Launches Global Research News Hub
WASHINGTON, March 7, 2019 /PRNewswire/ -- Across the globe, scores of lupus research studies are underway – more than any other...
Month: March 2019
63% of Hospital Leaders Say There is Clear ROI for Supply Chain Analytics Yet Almost Half Use Manual Processes to Manage Supply Chain Data
STRATFORD, Conn., March 7, 2019 /PRNewswire/ -- Eighty-seven percent of hospital leaders believe supply chain management can improve margins by more than...
Neonode Reports Fourth Quarter and Year Ended December 31, 2018 Financial Results
STOCKHOLM, March 7, 2019 /PRNewswire/ -- Neonode Inc. (NASDAQ: NEON), the Optical Interactive Sensing Technology Company, today reported financial results...
Welltok’s Tea Leaves Health Launches New Enterprise Growth Solution
DENVER, March 7, 2019 /PRNewswire/ -- More than ever, the consumer is at the center of today's leading health system growth...
ArisGlobal Launches LifeSphere Publishing as Key Component of LifeSphere Regulatory Cloud Platform
MIAMI, March 7, 2019 /PRNewswire/ -- ArisGlobal, a leading provider of life sciences software that automates core drug development functions...
ArisGlobal Launches Enterprise-Level Document Management Platform
MIAMI, March 7, 2019 /PRNewswire/ -- ArisGlobal, a leading provider of life sciences software that automates core drug development functions...
Kelyniam Announces 2018 Financial Results
COLLINSVILLE, Conn., March 7, 2019 /PRNewswire/ -- Kelyniam Global, Inc., (OTC: KLYG), a manufacturer of custom cranial implants has issued a...
Ravenswood and GDM Announce Strategic Partnership
FREMONT, Calif. and SAN JOSE, Calif., March 6, 2019 /PRNewswire/ -- Ravenswood Solutions, Inc., a leading provider of turnkey military training...
elminda and RI.Group to Form RI.Mind – a Joint Venture to Apply elminda’s Brain Analytics Technology for Personalization of Medical Cannabis
HERZLIYA, Israel, March 7, 2019 /PRNewswire/ -- elminda Ltd., a leading brain technology company, and RI.Group Investment Management Ltd., a...
Qure.ai Taps Former GE Healthcare Exec as Chief Commercial Officer
NEW YORK, March 7, 2019 /PRNewswire/ -- Qure.ai (http://www.qure.ai), a leading healthcare AI company, today announced Chiranjiv Singh has joined...
Elsevier Launches Assessment Capabilities on Its All-new ClinicalKey Student Platform
LONDON, March 7, 2019 /PRNewswire/ -- ClinicalKey Student equips medical faculty and students with the resources they need to enhance...
Stormont Vail Health Partners with Omnicell to Enhance Medication Management Strategy
MOUNTAIN VIEW, Calif., March 7, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Stormont Vail Health has selected Omnicell's...
CorMedix Inc. to Present at Roth and Oppenheimer & Co. Investor Conferences
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 11, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
ENDRA Life Sciences Reports Full Year 2018 Financial & Operational Results
Management to Host Full Year 2018 Conference Call Today at 4:30 p.m. ET ANN ARBOR, MI / ACCESSWIRE / March...
Easton Commences Cannabis Edibles Division and Announces Updates on Its Filing for the Period Ended December 31, 2018
TORONTO, ON / ACCESSWIRE / March 11, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces that it has commenced...
Cerecor Announces Closing of $10.0 Million Bought Deal of Common Stock
ROCKVILLE, MD / ACCCESSWIRE / March 11, 2019 / Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a...
Viveve Completes Enrollment in VIVEVE II Trial
Results could support a marketing application for an expanded U.S. indication for improvement of sexual function in women ENGLEWOOD, CO...
IntraBio Clinical Trial Authorisation Application Approved by the MHRA for the treatment of Niemann-Pick Disease Type C
OXFORD, UK / ACCESSWIRE / March 11, 2019 / IntraBio Inc., a late-stage biopharmaceutical company, today announced that the UK...
Nevada Hemp Licence Acquired
VANCOUVER, BC / ACCESSWIRE / March 11, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
ORYZON Announces FDA Approval of IND for ETHERAL, a Phase IIa trial of the Epigenetic Drug Vafidemstat in Patients with Mild to Moderate Alzheimer’s disease
Recruitment is ongoing in Europe; The European and US Study will recruit a total of 150 patients MADRID, SPAIN and...